PAREXEL has launched an Identification of Medicinal Products (IDMP)-focused solution, Liquent InSight, for biopharma companies.
PAREXEL has launched an Identification of Medicinal Products (IDMP)-focused solution, Liquent InSight, for biopharma companies. This solution will allow these companies to collect and submit data while meeting the International Organization Standardization (ISO) requirements for increased transparency.
Read the full release here
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.